Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 3, 2013, Pages

  Trappe, Todd A ^a   Standley, Robert A ^a   Jemiolo, Bozena ^a   Carroll, Chad C ^a   Trappe, Scott W ^a  

^a BALL STATE UNIVERSITY   (United States)

Author keywords

Acetaminophen; Ibuprofen; Sarcopenia

Indexed keywords

ARACHIDONIC ACID; ATROGIN 1; CYTOSOLIC PHOSPHOLIPASE A2; I KAPPA B KINASE BETA; IBUPROFEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MYOGENIC REGULATORY FACTOR 4; MYOGENIN; MYOSTATIN; PARACETAMOL; PHOSPHOLIPASE A2; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE GROWTH; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SKELETAL MUSCLE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; CYCLOOXYGENASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROPEPTIDES; PERFORMANCE-ENHANCING SUBSTANCES; PLACEBO EFFECT; PROSTAGLANDINS; RESISTANCE TRAINING;

EID: 84873278551     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00245.2012     Document Type: Article

References (70)

1. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM, Grygorczyk R. Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269: 2632-2636, 1994.
2. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284: E481-E487, 2003.
3. Bergstrom J. Muscle electrolytes in man. Scand J Clin Lab Invest 14: 7-110, 1962.
4. Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced tox-icity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31: 55-138, 2001.
5. Bodell PW, Kodesh E, Haddad F, Zaldivar FP, Cooper DM, Adams GR. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 106: 443-453, 2009.
6. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Ann Rev Pharm Tox 41: 661-690, 2001.
7. Burd NA, Dickinson JM, Lemoine JK, Carroll CC, Sullivan BE, Haus JM, Jemiolo B, Trappe SW, Hughes GM, Sanders, CE Jr Trappe TA. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab 298: E354-E361, 2010.
8. Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 23: 49-59, 2009.
9. Cai D, Frantz JD, Tawa NE, Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. IKKbeta/ NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298, 2004.
10. Carroll CC, Dickinson JM, Lemoine JK, Haus JM, Weinheimer EM, Hollon CJ, Aagaard P, Magnusson SP, Trappe TA. Influence of acetaminophen and ibuprofen on in vivo patellar tendon adaptations to knee extensor resistance exercise in older adults. J Appl Physiol 111: 508-515, 2011.
11. de Gonzalo-Calvo D, de Luxan-Delgado B, Rodriguez-Gonzalez S, Garcia-Macia M, Suarez FM, Solano JJ, Rodriguez-Colunga MJ, Coto-Montes A. Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: A translational approach. Cytokine 58: 193-198, 2012.
12. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14: 4443-4454, 1994.
13. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ. Serum IL-6 level and the development of disability in older persons. J Am GeriatrSoc47: 639-646, 1999.
14. Fiebich BL, Hull M, Lieb K, Gyufko K, Berger M, Bauer J. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J Neurochem 68: 704-709, 1997.
15. Fiebich BL, Schleicher S, Spleiss O, Czygan M, Hull M. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 79: 950-958, 2001.
16. Glass DJ. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol 346: 267-278, 2010.
17. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13, 2006.
18. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 98: 911-917, 2005.
19. Hamrin K, Rosdahl H, Ungerstedt U, Henriksson J. Microdialysis in human skeletal muscle: effects of adding a colloid to the perfusate. J Appl Physiol 92: 385-393, 2002.
20. Hanasaki K, Ono T, Saiga A, Morioka Y, Ikeda M, Kawamoto K, Higashino K, Nakano K, Yamada K, Ishizaki J, Arita H. Purified group X secretory phospholipase A2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J Biol Chem 274: 34203-34211, 1999.
21. Hansen M, Langberg H, Holm L, Miller BF, Petersen SG, Doessing S, Skovgaard D, Trappe T, Kjaer M. Effect of administration of oral contraceptives on the synthesis and breakdown of myofibrillar proteins in young women. Scand J Med Sci Sports 21: 62-72, 2011.
22. Hansen M, Trappe T, Crameri RM, Qvortrup K, Kjaer M, Langberg H. Myofibrillar proteolysis in response to voluntary or electrically stimulated muscle contractions in humans. Scand J Med Sci Sports 19: 75-82, 2009.
23. Haq S, Kilter H, Michael A, Tao J, O'Leary E, Sun XM, Walters B, Bhattacharya K, Chen X, Cui L, Andreucci M, Rosenzweig A, Guerrero JL, Patten R, Liao R, Molkentin J, Picard M, Bonventre JV, Force T. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med 9: 944-951, 2003.
24. Haus JM, Miller BF, Carroll CC, Weinheimer EM, Trappe TA. The effect of strenuous aerobic exercise on skeletal muscle myofibrillar proteolysis in humans. Scand J Med Sci Sports 17: 260-266, 2007.
25. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551, 2001.
26. Huey KA, McCusker RH, Kelley KW. Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10. J Neuroimmunol 199: 56-62, 2008.
27. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotox-icity. Drug Metab Dispos 31: 1499-1506, 2003.
28. Jemiolo B, Trappe S. Single muscle fiber gene expression in human skeletal muscle: validation of internal control with exercise. Biochem Biophys Res Commun 320: 1043-1050, 2004.
29. Komoto J, Yamada T, Watanabe K, Takusagawa F. Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry 43: 2188-2198, 2004.
30. α formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. Biochemistry 45: 1987-1996, 2006.
31. Kramer HF, Goodyear LJ. Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J Appl Physiol 103: 388-395, 2007.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method. Methods 25: 402-408, 2001.
33. Louis E, Raue U, Yang Y, Jemiolo B, Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 103: 1744-1751, 2007.
34. Malatkova P, Maser E, Wsol V. Human carbonyl reductases. Curr Drug Metab 11: 639-658, 2010.
35. α; stimulates PI3K/ ERK/mTOR signaling and skeletal myotube hypertrophy. Am J Physiol Cell Physiol 300: C671-C682, 2011.
36. Mindnich RD, Penning TM. Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum Genomics 3: 362-370, 2009.
37. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthase. Prost Other Lipid Mediat 68-69: 383-399, 2002.
38. α receptor in rat tissues. Prostaglandins Leukot Essent Fatty Acids 57: 527-532, 1997.
39. Palmer RM. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot Essent Fatty Acids 39: 95-104, 1990.
40. Palmer RM, Reeds PJ, Atkinson T, Smith RH. The influence of changes in tension on protein synthesis and prostaglandin release in isolated rabbit muscles. Biochem J 214: 1011-1014, 1983.
41. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119: 229-240, 2006.
42. Peake J, Della Gatta P, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 298: R1485-R1495, 2010.
43. Pedersen BK. Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107: 1006-1014, 2009.
44. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci 62: 1407-1412, 2007.
45. Raue U, Trappe TA, Estrem ST, Qian HR, Helvering LM, Smith RC, Trappe S. Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J Appl Physiol 112: 1625-1636, 2012.
46. Rodemann HP, Goldberg AL. Arachidonic acid, prostaglandin E2 and F2c influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257: 1632-1638, 1982.
47. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharm Rev 59: 207-224, 2007.
48. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23: 160-170, 2008.
49. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64: 1183-1189, 2009.
50. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761: 1246-1259, 2006.
51. Schieber A, Frank RW, Ghisla S. Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase. Eur J Biochem 206: 491-502, 1992.
52. St-Jacques B, Ma W. Role of prostaglandin E2 in the synthesis of the pro-inflammatory cytokine interleukin-6 in primary sensory neurons: an in vivo and in vitro study. J Neurochem 118: 841-854, 2011.
53. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285: E433-E437, 2003.
54. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 283: E1272-E1278, 2002.
55. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 282: 11613-11617, 2007.
56. Tesch PA, von Walden F, Gustafsson T, Linnehan RM, Trappe TA. Skeletal muscle proteolysis in response to short-term unloading in humans. J Appl Physiol 105: 902-906, 2008.
57. Thalacker-Mercer AE, Dell'Italia LJ, Cui X, Cross JM, Bamman MM. Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading. Physiol Genomics 40: 141-149, 2010.
58. Trappe T, Williams R, Carrithers J, Raue U, Esmarck B, Kjaer M, Hickner R. Influence of age and resistance exercise on human skeletal muscle proteolysis: a microdialysis approach. J Physiol 554: 803-813, 2004.
59. Trappe TA, Carroll CC, Dickinson JM, LeMoine JK, Haus JM, Sullivan BE, Lee JD, Jemiolo B, Weinheimer EM, Hollon CJ. Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am J Physiol Regul Integr Comp Physiol 300: R655-R662, 2011.
60. Trappe TA, Fluckey JD, White F, Lambert CP, Evans WJ. Skeletal muscle PGF2C. and PGE2 in response to eccentric resistance exercise: influence of ibuprofen and acetaminophen. J Clin Endocrinol Metab 86: 5067-5070, 2001.
61. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 282: E551-E556, 2002.
62. van Hall G, Steensberg A, Fischer C, Keller C, Moller K, Moseley P, Pedersen BK. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 93: 2851-2858, 2008.
63. Vandenburgh HH, Hatfaludy S, Sohar I, Shansky J. Stretch-induced prostaglandins and protein turnover in cultured skeletal muscle. Am J Physiol Cell Physiol 259: C232-C240, 1990.
64. Vella L, Caldow MK, Larsen AE, Tassoni D, Della Gatta PA, Gran P, Russell AP, Cameron-Smith D. Resistance exercise increases NF-kap-paB activity in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 302: R667-R673, 2012.
65. Wang P, Zhu F, Konstantopoulos K. Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Delta(12,14)-PGJ2. PLos One 6: e27630, 2011.
66. Wang P, Zhu F, Konstantopoulos K. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kB activation. Am J Physiol Cell Physiol 298: C1445-C1456, 2010.
67. Wang P, Zhu F, Lee NH, Konstantopoulos K. Shear-induced interleukin-6 synthesis in chondrocytes: roles of E prostanoid (EP) 2 and EP3 in cAMP/protein kinase A- and PI3-K/Akt-dependent NF-kappaB activation. J Biol Chem 285: 24793-24804, 2010.
68. Watanabe K. Prostaglandin F synthase. Prost Other Lipid Mediat 68-69: 401-407, 2002.
69. Weinheimer EM, Jemiolo B, Carroll CC, Harber MP, Haus JM, Burd NA, Lemoine JK, Trappe SW, Trappe TA. Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis. Am J Physiol Regul Integr Comp Physiol 292: R2241-R2248, 2007.
70. Yamada T, Komoto J, Watanabe K, Ohmiya Y, Takusagawa F. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2). JMol Biol 348: 1163-1176, 2005.